
pmid: 1923918
Phenytoin and dexamethasone are frequently administered concurrently to prevent consequences of central nervous system pathology. Limited and conflicting data are available regarding an interaction between the agents. A patient receiving dexamethasone required a daily phenytoin dose of greater than 10 mg/kg to maintain the phenytoin serum concentration within the usual therapeutic range. The concentration increased by nearly 300% after dexamethasone was discontinued.
Male, Brain Neoplasms, Metabolic Clearance Rate, Seizures, Phenytoin, Humans, Brain Edema, Drug Interactions, Adenocarcinoma, Middle Aged, Dexamethasone
Male, Brain Neoplasms, Metabolic Clearance Rate, Seizures, Phenytoin, Humans, Brain Edema, Drug Interactions, Adenocarcinoma, Middle Aged, Dexamethasone
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 55 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
